Cleared Traditional

Second Opinion CC (K242522) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242522 · Pearl, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2025
Decision
146d
Days
Class 2
Risk

K242522 is an FDA 510(k) clearance for the Second Opinion CC. Classified as Analyzer, Medical Image (product code MYN), Class II - Special Controls.

Submitted by Pearl, Inc. (Beverly Hills, US). The FDA issued a Cleared decision on January 16, 2025 after a review of 146 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2070 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Pearl, Inc. devices

Submission Details

510(k) Number K242522 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 2024
Decision Date January 16, 2025
Days to Decision 146 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 107d · This submission: 146d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MYN Analyzer, Medical Image
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2070
Definition For Information On The Myn Device, Please See: Https://www.federalregister.gov/documents/2020/01/22/2020-00494/radiology-devices-reclassification-of-medical-image-analyzers
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MYN Analyzer, Medical Image

All 36
Devices cleared under the same product code (MYN) and FDA review panel - the closest regulatory comparables to K242522.
Rayvolve LN
K243831 · AZmed · Mar 2025
Better Diagnostics Caries Assist (BDCA) Version 1.0
K241725 · Better Diagnostics AI Corp. · Mar 2025
ChestView US
K241620 · Gleamer Sas · Feb 2025
Velmeni for Dentists (V4D)
K240003 · Velmeni, Inc. · Aug 2024
Overjet Caries Assist-Pediatric
K233738 · Overjet, Inc. · Mar 2024
qXR-LN
K231805 · Qure.Ai Technologies · Dec 2023